https://cordis.europa.eu/project/id/268397/results/es
Wnt agonist Dickkopf 3 (DKK3) is a type 2 diabetes susceptibility gene | DKK3 T2DM | Proyecto |...
Deliverables, publications, datasets, software, exploitable results
https://researchportal.helsinki.fi/sv/publications/remission-of-t2dm-requires-early-diagnosis-and-substantial-weight/
Remission of T2DM requires early diagnosis and substantial weight reduction - Helsingfors...
early diagnosisweight reductionremissionrequires
https://www.all-imm.com/index.php/aei/article/view/1101
Effect of metformin on gut microbiota imbalance in patients with T2DM, and the value of probiotic...
https://brainasap.com/tag/t2dm/
t2dm Archives - Brain ASAP
This study shows that type 2 diabetes causes decreased blood flow and changes in neural activity in specific parts of the hippocampus, which may initially...
archivesbrainasap
https://www.morressier.com/o/event/59d4a17cd462b80296ca29f4/article/59d51844d462b80296ca3978
Efficacy & safety of teneligliptin when used as an add on to ongoing insulin therapy in Indian T2DM...
https://encyclopedia.pub/entry/6798
Green Space Exposure and T2DM | Encyclopedia MDPI
Encyclopedia is a user-generated content hub aiming to provide a comprehensive record for scientific developments. All content free to post, read, share and...
green spaceexposureencyclopediamdpi
https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428212/all/Long_term_follow_up_confirms_lack_of_mortality_benefit_of_strict_blood_sugar_control_in_T2DM
Long-term follow-up confirms lack of mortality benefit of strict blood sugar control in T2DM | EE+...
Long-term follow-up confirms lack of mortality benefit of strict blood sugar control in T2DM answers are found in the EE+ POEM Archive powered by Unbound...
https://www.derpharmachemica.com/abstract/sodiumglucose-cotransporter-2-sglt2-inhibitors-new-target-for-type-2-diabetes-mellitus-t2dm-review-15042.html
Sodium-glucose co-transporter 2 (SGLT2) Inhibitors: New Target for Type 2 Diabetes Mellitus (T2DM)...
Introduction: Knocking out type2 diabetes by new insulin independent renal glucose transporters as targets, reducing the side effects related to high ..
https://ctv.veeva.com/study/empagliflozin-versus-vildagliptin-in-cad-patients-with-t2dm
Empagliflozin Versus Vildagliptin in CAD Patients With T2DM
We compared the cardioprotective effects of empagliflozin, an SGLT2 inhibitor, with those of vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, focusing...
empagliflozinversusvildagliptincadpatients